Peter X. Shaw

7.4k total citations · 3 hit papers
55 papers, 5.2k citations indexed

About

Peter X. Shaw is a scholar working on Molecular Biology, Immunology and Ophthalmology. According to data from OpenAlex, Peter X. Shaw has authored 55 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Immunology and 12 papers in Ophthalmology. Recurrent topics in Peter X. Shaw's work include Atherosclerosis and Cardiovascular Diseases (24 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers) and Retinal Diseases and Treatments (11 papers). Peter X. Shaw is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (24 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (12 papers) and Retinal Diseases and Treatments (11 papers). Peter X. Shaw collaborates with scholars based in United States, China and Austria. Peter X. Shaw's co-authors include Joseph L. Witztum, Mi-Kyung Chang, Christoph J. Binder, Sohvi Hörkkö, Wulf Palinski, Karsten Hartvigsen, Gregg J. Silverman, Yury I. Miller, Asheesh K. Dewan and Sotirios Tsimikas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Peter X. Shaw

55 papers receiving 5.1k citations

Hit Papers

Pneumococcal vaccination decreases atherosclerotic lesion... 2000 2026 2008 2017 2003 2002 2000 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter X. Shaw United States 30 3.2k 1.5k 941 736 659 55 5.2k
Anil K. Chauhan United States 41 1.5k 0.5× 1.7k 1.1× 494 0.5× 441 0.6× 308 0.5× 129 5.3k
William A. Boisvert United States 36 2.3k 0.7× 2.7k 1.8× 1.2k 1.2× 1.6k 2.1× 329 0.5× 81 6.4k
Denan Jin Japan 36 1.5k 0.5× 1.5k 1.0× 299 0.3× 550 0.7× 184 0.3× 156 4.3k
Nancy R. Webb United States 45 805 0.3× 3.0k 2.0× 666 0.7× 2.1k 2.9× 176 0.3× 103 5.9k
Vincent Castronovo Belgium 49 1.6k 0.5× 4.2k 2.8× 239 0.3× 305 0.4× 671 1.0× 117 6.7k
Allan Sirsjö Sweden 32 1.2k 0.4× 1.3k 0.9× 426 0.5× 413 0.6× 190 0.3× 98 3.1k
Isabel Fabregat Spain 53 1.1k 0.3× 4.8k 3.3× 1.4k 1.5× 1.1k 1.5× 132 0.2× 168 8.8k
Qingzhong Xiao United Kingdom 44 1.1k 0.3× 3.3k 2.2× 546 0.6× 882 1.2× 119 0.2× 128 5.9k
Narin Osman Australia 36 842 0.3× 1.7k 1.2× 232 0.2× 643 0.9× 74 0.1× 90 3.5k
AJ Verhoeven Netherlands 28 2.0k 0.6× 1.1k 0.7× 199 0.2× 179 0.2× 178 0.3× 55 3.8k

Countries citing papers authored by Peter X. Shaw

Since Specialization
Citations

This map shows the geographic impact of Peter X. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter X. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter X. Shaw more than expected).

Fields of papers citing papers by Peter X. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter X. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter X. Shaw. The network helps show where Peter X. Shaw may publish in the future.

Co-authorship network of co-authors of Peter X. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Peter X. Shaw. A scholar is included among the top collaborators of Peter X. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter X. Shaw. Peter X. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biswas, Pooja, TJ Hollingsworth, Naheed W. Khan, et al.. (2025). Ablation of Htra1 leads to sub-RPE deposits and photoreceptor abnormalities. JCI Insight. 10(3). 1 indexed citations
2.
Lu, Zhigang, Victor S.‐Y. Lin, Fei Su, et al.. (2021). The interplay of oxidative stress and ARMS2-HTRA1 genetic risk in neovascular AMD. Vessel Plus. 2021. 14 indexed citations
3.
Su, Fei, et al.. (2021). Ongoing controversies and recent insights of the ARMS2-HTRA1 locus in age-related macular degeneration. Experimental Eye Research. 210. 108605–108605. 15 indexed citations
4.
Xu, Xiao, Zhigang Lu, Victor S.‐Y. Lin, et al.. (2018). MicroRNA miR‐24‐3p Reduces Apoptosis and Regulates Keap1‐Nrf2 Pathway in Mouse Cardiomyocytes Responding to Ischemia/Reperfusion Injury. Oxidative Medicine and Cellular Longevity. 2018(1). 7042105–7042105. 115 indexed citations
5.
Xu, Xiao, Huiyuan Hou, Victor S.‐Y. Lin, et al.. (2017). Probucol Protects Rats from Cardiac Dysfunction Induced by Oxidative Stress following Cardiopulmonary Resuscitation. Oxidative Medicine and Cellular Longevity. 2017(1). 1284804–1284804. 10 indexed citations
6.
Shaw, Peter X., et al.. (2016). Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury. Experimental Eye Research. 158. 33–42. 52 indexed citations
7.
Trakhtenberg, Ephraim F., Peter X. Shaw, Xiongfei Liu, et al.. (2015). The N-terminal Set-β Protein Isoform Induces Neuronal Death. Journal of Biological Chemistry. 290(21). 13417–13426. 10 indexed citations
8.
Wei, Xinran, Ling Zhao, Seanna Grob, et al.. (2012). A Novel Compound Heterozygous Mutation in the BEST1 Gene Causes Autosomal Recessive Best Vitelliform Macular Dystrophy. Investigative Ophthalmology & Visual Science. 53(14). 4560–4560. 1 indexed citations
9.
Tsimikas, Sotirios, Atsushi Miyanohara, Karsten Hartvigsen, et al.. (2011). Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression. Journal of the American College of Cardiology. 58(16). 1715–1727. 91 indexed citations
10.
Wang, Xiaolei, Jennifer N. Harmon, Yuhong Chen, et al.. (2010). Using the Utah Population Database to assess familial risk of primary open angle glaucoma. Vision Research. 50(23). 2391–2395. 24 indexed citations
11.
Zhang, Kang, Yuko Harada, Xinran Wei, et al.. (2010). An Essential Role of the Cysteine-rich Domain of FZD4 in Norrin/Wnt Signaling and Familial Exudative Vitreoretinopathy. Journal of Biological Chemistry. 286(12). 10210–10215. 34 indexed citations
12.
Chou, Meng-Yun, Linda Fogelstrand, Karsten Hartvigsen, et al.. (2009). Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. Journal of Clinical Investigation. 119(5). 1335–1349. 365 indexed citations
13.
Chou, Ming‐Yung, Karsten Hartvigsen, Lotte F. Hansen, et al.. (2008). Oxidation‐specific epitopes are important targets of innate immunity. Journal of Internal Medicine. 263(5). 479–488. 135 indexed citations
14.
Hartvigsen, Karsten, Meng-Yun Chou, Lotte F. Hansen, et al.. (2008). The role of innate immunity in atherogenesis. Journal of Lipid Research. 50. S388–S393. 112 indexed citations
15.
Witztum, Joseph L., Christoph J. Binder, Linda Fogelstrand, et al.. (2008). Natural Antibodies in Murine Atherosclerosis. Current Drug Targets. 9(3). 190–195. 32 indexed citations
16.
Choi, Seung‐Hyuk, et al.. (2007). Emerging approaches for imaging vulnerable plaques in patients. Current Opinion in Biotechnology. 18(1). 73–82. 10 indexed citations
17.
Miller, Yury I., Mi-Kyung Chang, Christoph J. Binder, Peter X. Shaw, & Joseph L. Witztum. (2003). Oxidized low density lipoprotein and innate immune receptors. Current Opinion in Lipidology. 14(5). 437–445. 139 indexed citations
18.
Shaw, Peter X., Carl S. Goodyear, Mi-Kyung Chang, Joseph L. Witztum, & Gregg J. Silverman. (2003). The Autoreactivity of Anti-Phosphorylcholine Antibodies for Atherosclerosis-Associated Neo-Antigens and Apoptotic Cells. The Journal of Immunology. 170(12). 6151–6157. 91 indexed citations
19.
Binder, Christoph J., Sohvi Hörkkö, Asheesh K. Dewan, et al.. (2003). Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nature Medicine. 9(6). 736–743. 590 indexed citations breakdown →
20.
Silverman, Gregg J., Peter X. Shaw, Marvin G. Chang, et al.. (2000). Neo-self Antigens and the Expansion of B-1 Cells: Lessons from Atherosclerosis-prone Mice. Current topics in microbiology and immunology. 252. 189–200. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026